An Expert’s View on Emerging Hodgkin Lymphoma Research

At the 2014 American Society of Hematology (ASH) meeting, leading researcher Dr. John Sweetenham joined Patient Power to discuss developing research in the treatment of Hodgkin lymphoma. Dr. Sweetenham explored studies discussed at the conference, including studies into non-chemotherapy approaches, trials for people with relapsed disease, and the potential for a cure in the future.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo